LNSR
LENSAR, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$7.07
−0.28%Research · Aug 25, 2026
Cataract Surgery Stops Growing in the US
Alcon and Bausch + Lomb reported flat US cataract volume in Q2 2026; growth now comes from premium intraocular lenses, worth $15 million a point to Alcon.